Posluszny Donna M, Nezu Arthur M, Bovbjerg Dana H, Syrjala Karen L, Dew Mary Amanda
University of Pittsburgh, Pittsburgh, USA.
UPMC Hillman Cancer Center, Pittsburgh, USA.
J Clin Psychol Med Settings. 2025 Apr 26. doi: 10.1007/s10880-025-10078-0.
Allogeneic hematopoietic cell transplantation (HCT) can be a lifesaving treatment for patients with hematologic disease. However, adherence to the post-HCT clinical regimen has many challenges that patients and their family caregivers must manage after hospital discharge. To address their needs, we developed a Dyadic Problem-Solving Therapy (DPST) intervention, then examined its feasibility and acceptability to patients and their family caregivers. Twelve patient-family caregiver dyads participated. Four dyads received DPST in person, four received it via online video conferencing. Another four received an enhanced usual care (EUC) intervention of the same length. Feasibility was assessed using completion rates, while acceptability was assessed using satisfaction ratings on the Client Satisfaction Questionnaire. DPST and EUC were both feasible (100% of dyads who started the intervention completed it) and acceptable with satisfaction ratings ranging from 3.6 to 4 for patients and 3.6-3.9 for family caregivers on a 1-4 scale for both DPST groups and ranging from 3.3 to 3.8 for EUC patients and 3.5-4 for EUC family caregivers. There were no evident differences by mode of intervention delivery. DPST, both in person and via video, appears feasible and acceptable for training patient-family caregiver dyads to manage challenges to adherence to the post-HCT regimen.
异基因造血细胞移植(HCT)对血液病患者而言可能是一种挽救生命的治疗方法。然而,在出院后,患者及其家庭照护者必须应对诸多挑战以坚持HCT后的临床治疗方案。为满足他们的需求,我们开发了一种二元问题解决疗法(DPST)干预措施,随后检验了其对患者及其家庭照护者的可行性和可接受性。12对患者 - 家庭照护者参与其中。4对接受了面对面的DPST,4对通过在线视频会议接受了该疗法。另外4对接受了时长相同的强化常规护理(EUC)干预。使用完成率评估可行性,使用《客户满意度调查问卷》中的满意度评分评估可接受性。DPST和EUC均可行(开始干预的二元组中有100%完成了干预),且可接受,DPST组患者的满意度评分在1 - 4分制中为3.6至4分,家庭照护者为3.6 - 3.9分;EUC患者的满意度评分在3.3至3.8分之间,EUC家庭照护者为3.5 - 4分。干预实施方式上没有明显差异。无论是面对面还是通过视频方式进行的DPST,对于培训患者 - 家庭照护者二元组应对坚持HCT后治疗方案所面临的挑战而言,似乎都是可行且可接受的。
J Clin Psychol Med Settings. 2025-4-26
Cochrane Database Syst Rev. 2016-10-6
Cochrane Database Syst Rev. 2016-11-24
Health Technol Assess. 2025-7
Pilot Feasibility Stud. 2024-4-6
Biol Blood Marrow Transplant. 2020-9
Am Health Drug Benefits. 2017-10